Last update 20 Jan 2026

AP601

Overview

Basic Info

Drug Type
Bispecific antibody
Synonyms
AP601
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsDigestive System DisordersRespiratory Diseases+ [1]
Active Indication
Colorectal CancerNon-Small Cell Lung CancerTriple Negative Breast Cancer+ [1]
Inactive Indication-
Originator Organization
AP Biosciences, Inc.AP Biosciences, Inc.
Active Organization
AP Biosciences, Inc.AP Biosciences, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with AP601
NCT07165067
/ RecruitingPhase 1
A Phase 1, Open-label Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Activity of AP601 in Patients With Solid Tumors.
100 Clinical Results associated with AP601
Login to view more data
100 Translational Medicine associated with AP601
Login to view more data
100 Patents (Medical) associated with AP601
Login to view more data
100 Deals associated with AP601
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Colorectal CancerPhase 1
Australia
AP Biosciences, Inc.AP Biosciences, Inc.
21 Jan 2026
Non-Small Cell Lung CancerPhase 1
Australia
AP Biosciences, Inc.AP Biosciences, Inc.
21 Jan 2026
Triple Negative Breast CancerPhase 1
Australia
AP Biosciences, Inc.AP Biosciences, Inc.
21 Jan 2026
NeoplasmsPreclinical
Taiwan Province
AP Biosciences, Inc.AP Biosciences, Inc.
30 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free